Metromalacia refers to a medical condition that affects the uterus, specifically the endometrium, which is the inner lining of the uterus. This condition is characterized by a softening, weakening, or degeneration of the endometrium. The term "metromalacia" is derived from the Greek words "metros" meaning uterus and "malakia" meaning softening.
Metromalacia can be attributed to various factors such as hormonal imbalances, inflammation, or ischemia (a decrease in blood supply). It is most commonly associated with excessive or prolonged estrogen exposure. This condition is often observed in women who have experienced multiple pregnancies, chronic endometrial inflammation, or prolonged use of estrogen-only hormonal therapy.
Symptoms of metromalacia may include irregular or heavy menstrual bleeding, pelvic pain, discomfort during sexual intercourse, and fertility issues. Although these symptoms may be indicative of other gynecological conditions as well, a medical diagnosis is necessary to confirm the presence of metromalacia.
Treatment options for metromalacia depend on the severity of symptoms and the individual's desire for future fertility. Conservative management may include hormonal therapy to regulate the menstrual cycle or the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain. In more severe cases, surgical intervention, such as endometrial ablation or hysterectomy, may be considered to alleviate symptoms.
It is important for individuals experiencing symptoms associated with metromalacia to consult with a healthcare professional for an accurate diagnosis and appropriate management.
